• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, November 17, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Machine Learning Model Identifies Ultrasound-Defined MASLD in Overweight Children

by
November 9, 2026
in Health, Technology
Reading Time: 2 mins read
0
Machine Learning Model Identifies Ultrasound-Defined MASLD in Overweight Children

Machine Learning Model Identifies Ultrasound-Defined MASLD in Overweight Children

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A stacking ensemble machine learning model built on routinely available clinical data demonstrated good discrimination for identifying ultrasound-defined metabolic dysfunction-associated steatotic liver disease in children with overweight or obesity, according to a retrospective multicenter study published in BMC Medical Informatics and Decision Making.

Metabolic dysfunction-associated steatotic liver disease increasingly accompanies childhood obesity, establishing an ongoing clinical need for accessible screening approaches that can be integrated into routine pediatric care.

Researchers conducted a retrospective multicenter investigation utilizing outpatient records from two hospital centers to evaluate overweight and obese children aged 5 to 16 years. The model development cohort included 7,454 pediatric patients from Nanjing, comprising 3,475 disease events and 3,979 non-events, while an independent external validation set included 353 children from Suzhou, consisting of 129 events and 224 non-events.

The study determined steatotic liver disease status through abdominal ultrasound evaluations. Across the evaluated clinical records, investigators gathered 46 routine clinical variables spanning anthropometric measurements, standard blood tests, and biochemical indicators to construct a stacking ensemble framework combining ten machine learning algorithms.

In development set evaluations using patient-level out-of-fold predictions from 10-fold cross-validation, the ensemble model achieved an area under the receiver operating characteristic curve of 0.877, alongside an area under the curve of 0.865 in the independent external validation set. Complementary feature-contribution analysis using SHAP for the AdaBoost base classifier showed that liver enzymes and metabolic markers served as major contributors to model predictions.

External validation revealed an overprediction of absolute risk, demonstrating that the stacking ensemble model requires additional recalibration and broader validation in larger and more diverse pediatric populations before routine clinical deployment, while a web-based application was created to display individualized outputs.

The researchers noted that because the model was built entirely on routinely available clinical indicators—encompassing routine blood tests, anthropometric measurements, and biochemical markers—it offers an accessible framework for evaluating pediatric metabolic dysfunction-associated steatotic liver disease in outpatient settings. In particular, the authors concluded that this multicenter machine-learning approach may support future clinical identification of ultrasound-defined disease in overweight and obese children once further validation and recalibration are achieved.

Subject of Research: Machine learning model for ultrasound-defined pediatric MASLD screening

Article Title: Development and external validation of a stacking ensemble machine-learning model to identify ultrasound-defined MASLD in children with overweight or obesity

Article References: Yan, W., Shi, X., Hua, J., Zhao, B., Huang, C., Peng, L., Zhou, N., Hao, J., Bai, R., Liu, Q., & Li, X. (2026). Development and external validation of a stacking ensemble machine-learning model to identify ultrasound-defined MASLD in children with overweight or obesity. BMC Medical Informatics and Decision Making. https://doi.org/10.1186/s12911-026-03872-9

Image Credits: AI Generated

DOI: 10.1186/s12911-026-03872-9

Keywords: Machine Learning, Pediatric MASLD, Childhood Obesity, Abdominal Ultrasound, Clinical Prediction, Ensemble Learning, Medical Informatics, Pediatric Hepatology, Development, external, validation, stacking

News Source: Teresa Odom. (November 9, 2026). Machine Learning Model Identifies Ultrasound-Defined MASLD in Overweight Children. Scienmag.

Tags: abdominal ultrasoundChildhood obesityclinical predictionDevelopmentensemble learningexternalMachine LearningMedical InformaticsPediatric hepatologyPediatric MASLDstackingValidation
Share12Tweet7Share2ShareShareShare1

Related Posts

Higher Body Mass Index Linked to Reduced Osteoporosis Risk

Higher Body Mass Index Linked to Reduced Osteoporosis Risk

November 17, 2026
Five Clinical Factors Predict Diabetic Retinopathy Risk in Type 2 Diabetes

Five Clinical Factors Predict Diabetic Retinopathy Risk in Type 2 Diabetes

November 17, 2026

Abdominal CT Radiomics Identifies Prevalent Heart Disease in Type 2 Diabetes

November 17, 2026

Researchers Propose D-Allulose Framework to Test Metabolic Signaling and Aging

November 17, 2026

POPULAR NEWS

  • Five Clinical Factors Predict Diabetic Retinopathy Risk in Type 2 Diabetes

    Five Clinical Factors Predict Diabetic Retinopathy Risk in Type 2 Diabetes

    29 shares
    Share 12 Tweet 7
  • Abdominal CT Radiomics Identifies Prevalent Heart Disease in Type 2 Diabetes

    29 shares
    Share 12 Tweet 7
  • Researchers Propose D-Allulose Framework to Test Metabolic Signaling and Aging

    29 shares
    Share 12 Tweet 7
  • Gut Microbiome Shifts Linked to Depressive Symptoms in Diabetes Patients

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Higher Body Mass Index Linked to Reduced Osteoporosis Risk

Five Clinical Factors Predict Diabetic Retinopathy Risk in Type 2 Diabetes

Abdominal CT Radiomics Identifies Prevalent Heart Disease in Type 2 Diabetes

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.